Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Lupus. 2013 Nov;22(13):10.1177/0961203313508444. doi: 10.1177/0961203313508444

Table 3.

List of clinical symptoms observed in SLE and MCTD patients

Clinical symptom name Definition SLE
MCTD
p-
value
Positive Total Positive Total
Skin telangiectasia Vascular lesions formed by dilation of small blood
vessels
5% 79 15% 40 0.0650
Skin nasal/oral ulcers Shallow and painful open sores that appear as necrotic
or eroded areas on the oral mucosa
29% 79 23% 39 0.4880

Raynaud’s syndrome Vascular disorder causing periods of severely restricted
blood flow to the fingers and toes
53% 80 85% 40 0.0001
History of hand swelling Hand swelling by history 41% 81 61% 41 0.0120
Observed hand swelling Hand swelling observed on physical exam at the date of
visit
19% 81 39% 41 0.0140
Acrosclerosis Scleroderma of the distal extremities, sometimes
extending to the neck and face
4% 80 26% 38 0.0001

Skin digital pitting Loss of skin on the tips of the fingers caused by scars
and ulcers
8% 80 8% 39 0.9700
Proximal scleroderma Skin fibrosis of the extremities proximal to the elbows
or knees, or of the thorax.
3% 79 0% 39 0.3160
Skin alopecia Hair loss condition that usually affects the scalp 58% 80 72% 39 0.1310

Malar rash Skin rash of both cheeks joined by an extension across
the bridges of the nose
46% 78 13% 39 0.0001
Discoid rash Chronic skin problem resulting from lupus disease 10% 78 0% 39 0.0380

Skin rash Red and swollen area on the skin 33% 78 38% 39 0.5840
Skin photosensitivity Skin rash resulting from reaction to sunlight 57% 76 58% 38 0.8940
Skin calcinosis Abnormal deposition of calcium salts in tissues 1% 79 5% 38 0.2000
Sicca, xerophthalmia and
xerostomia
Characterized by dry eyes (xerophthalmia) and dry
mouth (xerostomia)
49% 81 66% 41 0.1330
Erosive inflammatory
arthritis
Synovitis with joint erosions 43% 23 45% 20 0.9200
Lymphadenopathy Swollen or enlarged lymph nodes 24% 79 20% 40 0.6180
Fever Increase in body temperature above the normal range
(98–100°F)
22% 78 15% 40 0.7780

Proximal muscle weakness Malfunction of muscle fibers resulting in weakness 29% 76 49% 39 0.0360
Myositis Inflammation of muscle tissue 6% 79 27% 33 0.0020

Myalgia Tenderness or pain in the muscles 54% 80 48% 40 0.8970
Morning stiffness Joint and muscle stiffness present upon awakening 53% 73 64% 36 0.3000

Swelling of three or more
joints
Multiple joints swelling 42% 78 63% 40 0.0380
Joint tenderness Sensitivity to touch or pressure on fat pad, tendon
attachment, ligament, muscle and/or skin
35% 79 69% 39 0.0010
Joint swelling Intra-articular effusion, synovial thickening, and
periarticular soft tissue inflammation
29% 78 63% 40 0.0010
Symmetric swelling Swelling occurs in the same joint on both sides of the
body
27% 78 64% 39 0.0001

Rheumatoid nodule Includes subcutaneous nodules over bony prominences,
extensor surface or in juxta articular regions
6% 77 10% 40 0.5000
Arthralgia Joint pain 82% 79 84% 38 0.7950
Neuropathy Any type of nerve disorders 31% 77 28% 40 0.6810
Seizure A sudden attack of pain, of a disease, or of certain
symptoms
4% 80 0% 40 0.2150
Psychosis Any mental disorder characterized by personality
disintegration and loss of contact with reality
3% 79 0% 39 0.3160

Neuropsychiatric disorder Evidence of mental illness 19% 78 51% 39 0.0001

Hypomotility in cine
deglutition esophageal
Decreased motility of the esophagus (usually results in
difficulty swallowing or increased acid reflux)
41% 78 58% 40 0.0890
Pulmonary fibrosis Development of excess fibrous connective tissue in the
lungs
22% 45 23% 26 0.6330
Pleuritic pain or rubbing
heard
Inflammation of membrane that enfolds both lungs 37% 78 23% 39 0.1250
Pericarditis Inflammation of the pericardium 30% 73 18% 39 0.1610
Avascular necrosis Cellular death of bone components due to interruption
of the blood supply
3% 74 0% 33 0.3040

Clotting Thick, viscous, or coagulated mass in blood stream. 1% 75 12% 34 0.0160
Myocardial infarction Partial or complete occlusion of one or more of the
coronary arteries resulting in myocardial injury
0% 73 11% 35 0.0030

Stroke Brain hemorrhage or lack of blood flow 6% 81 2% 41 0.3570

Clinical manifestations that differ significantly between SLE and MCTD patients are highlighted in gray (p ≤ 0.05). Neuropathy, seizure and psychosis symptoms were diagnosed in the absence of offending drugs or known metabolic derangements.